Becton Dickinson is getting into pharmacies with a more than $1.5 billion acquisition of Parata Systems, maker of robotics technologies that automate pharmacy tasks. The deal comes two months after BD completed the spinoff of its diabetes business as a separate, publicly traded company.
The second quarter of 2022 kicked off with a new life sciences company joining the public markets, but not via an IPO or merger. Becton Dickinson on Friday completed the spinoff of its diabetes care business, Embecta, which now trades on the Nasdaq.
The progress in artificial intelligence (AI) is reshaping patient care, across various dimensions, from facilitating faster discharge to curating treatment plans and suggesting lifestyle changes.
Becton Dickinson is known worldwide for its diabetes products. Now the medical technologies giant plans to spin off its diabetes care business as a separate, publicly traded company, leaving BD to focus on its other core segments.
Last month, medical device company Ivenix received clearance for a new smart infusion pump meant to address the safety issues endemic to the industry with more streamlined and intuitive technology.
One reason for the deal is Bard will help expand BD’s focus on the treatment of disease states beyond diabetes.
Medical technology manufacturer Becton Dickinson (NYSE: BDX) has acquired a collaboration partner that produces handheld, electronic diagnostic devices. They are designed to be used at the point of care in places like physician offices, retail clinics and patient homes. The $40 million deal to take over San Jose healthcare technology company Alverix will help it […]
Zelis CEO Amanda Eisel shares her perspective on how the company is solving the problems of a fragmented health financial system to benefit all.
The developer of a digital medical device that tests for different respiratory illnesses, such as flu A and B strains and strep A, sees additional scope for the respiratory test as a testing platform for sexually transmitted diseases along with a broader range of infectious diseases. The BD Veritor System, developed by Alverix and marketed […]
Diagnostics firm Advanced Animal Diagnostics has closed an $11 million series B round. The Durham, North Carolina-based company is developing a test for mastitis in dairy cows.
Contrary to popular health economic wisdom, the group purchasing organization raises costs for hospitals, according to a study by two respected economists, writes the Health Populi blog. Meanwhile, the Health Industry Group Purchasing Association tried to get ahead of the negative industry study (pdf) with promises of members being ahead of health reforms that would reduce cost.
Aspen Surgical Products Inc. has acquired the blades and scalpels business of Becton, Dickinson and Co. for an undisclosed sum. Aspen’s acquisition of BD’s Bard-Parker business beefs up its line of products for operating room use, according to a statement from RoundTable HealthCare Partners, the Illinois-based private equity firm that owns Aspen. Aspen sells a […]
When it comes to managing inbound phone calls, underperformance has devastating cost implications.
The U.S. Food & Drug Administration said it is requiring nine medical device companies to conduct postmarket analysis on a connection between needless connectors and higher rates of blood stream infections. In a notice posted on the Centers for Devices and Radiological Health web site, officials said that the agency is “aware of information that […]
Becton, Dickinson & Co. expands the Class I recall of millions of its Q-Syte Luer access intravenous systems to include its Nexiva IV catheter.